Source: Drug Safety. Conference titles: International Society of Pharmacovigilance/ISoP. Unidades: HU, FCF
Subjects: RECÉM-NASCIDO, MEDICAMENTO, FARMACOVIGILÂNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FABRETTI, Sandra de Carvalho et al. Triggers of active surveillance of adverse drug events in hospitalized newborns: a pilot study. Drug Safety. Auckland: Hospital Universitário, Universidade de São Paulo. . Acesso em: 10 out. 2024. , 2015APA
Fabretti, S. de C., Lieber, N. S. R., Brassica, S. C., Ribeiro, E., & Hernandez, C. D. (2015). Triggers of active surveillance of adverse drug events in hospitalized newborns: a pilot study. Drug Safety. Auckland: Hospital Universitário, Universidade de São Paulo.NLM
Fabretti S de C, Lieber NSR, Brassica SC, Ribeiro E, Hernandez CD. Triggers of active surveillance of adverse drug events in hospitalized newborns: a pilot study. Drug Safety. 2015 ; 38( 10): 847-1048.[citado 2024 out. 10 ]Vancouver
Fabretti S de C, Lieber NSR, Brassica SC, Ribeiro E, Hernandez CD. Triggers of active surveillance of adverse drug events in hospitalized newborns: a pilot study. Drug Safety. 2015 ; 38( 10): 847-1048.[citado 2024 out. 10 ]